0001209191-24-002967.txt : 20240207
0001209191-24-002967.hdr.sgml : 20240207
20240207185218
ACCESSION NUMBER: 0001209191-24-002967
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240205
FILED AS OF DATE: 20240207
DATE AS OF CHANGE: 20240207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chacko David M.
CENTRAL INDEX KEY: 0001871801
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40602
FILM NUMBER: 24606291
MAIL ADDRESS:
STREET 1: C/O ERASCA, INC.
STREET 2: 10835 ROAD TO THE CURE, SUITE 140
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Erasca, Inc.
CENTRAL INDEX KEY: 0001761918
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 831217027
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10835 ROAD TO THE CURE, SUITE 140
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 465-6511
MAIL ADDRESS:
STREET 1: 10835 ROAD TO THE CURE, SUITE 140
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-02-05
0
0001761918
Erasca, Inc.
ERAS
0001871801
Chacko David M.
C/O ERASCA, INC.
3115 MERRYFIELD ROW, SUITE 300
SAN DIEGO
CA
92121
0
1
0
0
CFO and CBO
0
Stock Option (right to buy)
1.70
2024-02-05
4
A
0
600000
0.00
A
2034-02-04
Common Stock
600000
600000
D
1/48th of the shares subject to the option vest monthly, with vesting starting on February 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
/s/ Ebun Garner, attorney-in-fact
2024-02-07